baber/WOPTO huggingface dataset:
Patent IE-800070-L (IE)
Title: Treatment of contact lenses
IPC: C11D7/16
Filed: 1980-01-14
Abstract: The invention relates generally to a method and composition for the treatment of contact lenses, especially silicone and hydrophilic plastic contact lenses, to remove inorganic deposits and to prevent the formation of inorganic deposits on the lenses. One of the problems connected with these types of lenses is the formation, over a period of time, of insoluble inorganic deposits on the lenses. These deposits are thought to be primarily calcium based, e.g., calcium phosphate and calcium carbonate, but may also contain other inorganic materials and associated organic materials, e.g., protein. The presence of these insoluble inorganic deposits is a common cause of lens intolerance and decreased visual acuity. The method comprises contacting a contact lens with an aqueous solution containing an effective amount of a polymetaphosphate, gluconic acid or salts thereof as sequestering agent for a period of time sufficient to remove existing inorganic deposits and to prevent formation of inorganic deposits. The solution may be a preserved saline solution containing 0.01-20% by weight of the sequestering agent.
[GB2040492A]
Patent IE-780116-L (IE)
Title: Aqueous sizing compositions for coating glass fibres
IPC: C03C25/10
Filed: 1978-01-18
Abstract: The invention is relative to aqueous compositions for the glass fiber coating intended in particular for the textile applications or the thermohardening or thermoplastic synthetic resin recess. [FR2377982A1]
Patent IE-35156-L (IE)
Title: Production of n-(trisubstituted methyl)-azoles.
IPC: C07D405/04
Filed: 1971-02-02
Abstract: N-(1,1,1-trisubstituted)-methylazoles are produced by reacting thionyl-imidazole with a substituted carbinol of the formula: B ¦ A-C-D ¦ OH wherein A is aliphatic, cycloaliphatic, aromatic or heteroaromatic, B is aliphatic, cycloaliphatic, aromatic or a 5- or 6-membered heteroaromatic ring having 1 to 3 N-heteroatoms or 1 or 2 N-heteroatoms plus an oxygen or sulphur heteroatom and D is aliphatic, cycloaliphatic, aromatic, alkoxycarbonyl, alkoxycarbonylalkyl, aryloxycarbonyl or a 5- or 6-membered heteroaromatic ring having 1 to 3 N-heteroatoms or 1 or 2 N-heteroatoms plus an oxygen or sulphur heteroatom and related carbinols. The reactants are in 1:1 molar ratio and the reaction is carried out in dry inert solvents at a temperature of -20 DEG C. to +150 DEG C.
[US3897438A]
Patent IE-37169-L (IE)
Title: Benzo-1, 2, 4-triazine derivatives
IPC: A23K20/195
Filed: 1973-01-31
Abstract: 1,2,4-Benzotriazines-1,4-di-N-oxides having an amino compound in the 3-position, preferably with a further substituent in one or both of the 6- and 7-positions, are antimicrobial agents. The compounds, of which 6-chloro-3-amino-1,2,4-benzotriazine-1,4-di-N-oxide and 7-chloro-3-amino-1,2,4-benzotriazine-1,4-di-N-oxide are typical examples, are prepared through treatment of the appropriately substituted benzofuroxan with cyanamide under basic conditions followed by acidification.
[US3868371A]
Patent IE-34210-L (IE)
Title: Catalytic epoxidation of olefins.
IPC: C07D301/19
Filed: 1970-04-01
Abstract: 1,249,082. Epoxidation catalysts. SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ N.V. 1 April, 1970 [2 April, 1969], No. 15376/70. Heading B1E. [Also in Division C2] Catalysts for use in the epoxidation of olefinic compounds by treatment with organic hydroperoxides comprise zirconium in chemical combination with silica and/or an inorganic silicate. Preferably the catalyst has a specific surface area of at least 1m<SP>2</SP>/g. In addition to the zirconium compound there may be present in the catalyst a promoter, e.g. a compound of magnesium, calcium, strontium or barium. There may also be present in the catalyst up to 10% by weight of an oxide or hydroxide of boron, tin niobium, tantalum, chromium, molybdenum, tungsten, rhenium, uranium, bismuth or a rare earth metal (atomic number 57-71). For comparative purposes examples are given of the use as catalyst of zirconium on a number on non-siliceous supports, metals other than zirconium on silica and various metallic compounds without siliceous compounds.
[GB1249082A]
Patent IE-880438-L (IE)
Title: Heterocyclic compounds and their preparation and use
IPC: C07D471/14
Filed: 1988-02-18
Abstract: New heterocyclic compounds having the general formula <CHEM> wherein R' and R'' independently are C1-6-alkyl, C3-7-cycloalkyl or C1-6-alkoxymethyl; -A- is -C(=O)-NR'''-, -NR'''-C(=O)-, or <CHEM>  wherein R''' is C1-6-alkyl;  X is C or N; and R<4> is hydrogen, halogen, CN, C1-6-alkyl, C1-6-alkynyl, trimethylsilyl-C1-6-alkynyl, aryloxy which may be substituted with halogen, aralkoxy, C3-7-cycloalkoxy which may be substituted with one or more C1-6-alkyl groups,or NR''''R''''', wherein R'''' and R''''' independently are C1-6-alkyl or together with the nitrogen atom form a 3-7 membered heterocyclic ring. The compounds are useful in psychopharmaceutical preparations as anticonvulsants, anxiolytics, hypnotics, and nootropics.
Patent IE-35176-L (IE)
Title: Improvements in the production of edible protein containing¹substances
IPC: A23J3/20
Filed: 1971-04-29
Abstract: The invention relates to Fusarium graminearum Schwabe deposited with the Commonwealth Mycological Institute and assigned the number IMI 145425 and variants and mutants thereof, as well as a culture medium containing the same.
[US4294929A]
Patent IE-790564-L (IE)
Title: Detergent bleach composition.
IPC: D06L4/50
Filed: 1979-08-08
Abstract: Combined washing and bleaching of fabrics is accomplished by use of a composition comprising a mixture of surfactant, peroxy bleach, and porphine bleach. The surfactant is anionic, nonionic, semi-polar, ampholytic, zwitterionic, or cationic in nature. The peroxy bleach is inorganic or organic. The porphine bleach is a porphine or a mono-, di-, tri-, or tetra-aza porphine, solubilized with anionic, nonionic and/or cationic substituent groups, and metal free or metallated with Zn(II), Cd(II), Mg(II), Ca(II), Al(III), Sc(III) or Sn(IV).
[US4240920A]
Patent IE-35431-L (IE)
Title: Pyrrole derivatives
IPC: C07D209/58
Filed: 1971-05-24
Abstract: 1335129 Dibenzocyclohepta[1,2-c]pyrrole CIBA-GEIGY AG 25 May 1971 [25 May 1970] 16661/71 Heading C2C [Also in Division C5] Novel compounds of the Formula (I) wherein R denotes H, C 1-4 alkyl or allyl, and X denotes H, Cl, CH 3 or CH 3 O, and the addition salts with inorganic or organic acids, may be obtained (1) by reacting a reactive ester of a compound of the Formula II with ammonia or an amine of formula RNH 2 , or (2) by hydrolysing a compound of the Formula IV wherein Z denotes the acyl radical of an organic acid or the cyano group, and when required converting the product into a pharmaceutically acceptable acid addition salt thereof. The preparation of intermediates is described as follows: (9,10-dihydroanthracen-9-yl)methyl ketone is methylated with CH 3 I to give (9- methyl-9,10-dihydroanthracen-9-yl)methyl ketone which is reduced by NaBH 4 to α, 9-dimethyl-9,10- dihydro-9-anthracenemethanol which is rearranged, according to Wagner-Meerwein, in dilute H 2 SO 4 and rearranged to 10,11-dimethyl-5H- dibenzo[a,d]cycloheptene. This latter product can also be obtained by condensing α-phenyl-o-tolylacetonitrile with diethylcarbonate to α-phenyl-otolylcyano-acetic acid ethyl ester, methylating with CH 3 I and boiling with KOH solution to form o-benzyl-hydratropic acid, converting in polyphosphoric acid to 11-methyl-5,11-dihydro- 10H-dibenzo[a,d]cycloheptene-10-one, reacting with CH 3 MgI to form 10,11-dimethyl-10,11- dihydro-5H-dibenzo[a,d]cyclohepten-10-ol and dehydrating in H 2 SO 4 to form 10,11-dimethyl-5H- dibenzo[a,d]cycloheptene. Similar intermediates substituted in the 2-position by chlorine, methyl or methoxy can likewise be obtained. The 10,11- dimethyl-5H-dibenzo[a,d]cycloheptene can be oxidized with SeO 2 to 5H-dibenzo[a,d]cycloheptene-10,11-dicarboxaldehyde which is reduced with NaBH 4 to 5H-dibenzo[a,d]cycloheptene- 10,11-dimethanol which reacts with PBr 3 to form 10,11 - bis - bromomethyl - 5H - dibenzo[a,d]cycloheptene, a compound of Formula II. Corresponding Cl-, CH 3 - and CH 3 O- intermediate compounds are similarly obtained.1,2,3,8-Tetrahydrodibenzo[3,4 : 6,7]cyclohepta[1,2-c]pyrrole - 2-carboxylic acid ethyl ester is obtained by reacting 2 - allyl - 1,2,3,8 - tetrahydrodibenzo[3,4 : 6,7]- cyclohepta[1,2-c] pyrrole with ethyl chloroformate. Pharmaceutical compositions possessing CNS depressant action, adrenolytic and histamineantagonistic action, comprise compounds of Formula (1) above or pharmaceutically acceptable acid addition salts thereof together with a pharmaceutically acceptable carrier or diluent, in forms suitable for administration orally, rectally or parenterally.
[GB1335129A]
Patent IE-790869-L (IE)
Title: Pregnadienes and -trienes
IPC: C07J71/00
Filed: 1979-08-08
Abstract: The invention relates to a new process for the preparation of 6 alpha -halo-3-keto- DELTA 1,4-pregnadiene-derivatives in two-steps-synthesis affording directly 6 alpha -halo-derivatives by reacting 3-keto-9 beta ,11 beta -oxido- DELTA 1,4-pregnadiene-derivatives with a suitable acylating or etherifying agent to give the corresponding new 3-enol-derivatives which are finally halogenated by using a suitable halogenating agent.
[US4188322A]
Patent IE-34375-L (IE)
Title: Necktie hanger
IPC: A47G25/74
Filed: 1970-07-09
Abstract: 1,262,228. Neck-tie racks. DART INDUSTRIES Inc. July 16, 1970 [July 16, 1969], No.34616/70. Heading A4U. A hanger for neck ties and clothing accessories comprises a head 2, formed as a hook for engagement with a hanger rail, the base of the hook being joined by a bar, having upper and lower projections for retention of a tie clip 11, to a body 10, having the racks and apertures of different sizes to receive tie tacks and cuff links 15, and a lower base portion 20 formed with hooks 24 to receive accessories such as belts 17.
[GB1262228A]
Patent FI-823317-L (FI)
Inventor: RAISIO REIJO
IPC: B60P1/48
Filed: 1982-09-27
Abstract: Equipment for loading an exchange platform or a container onto a truck or truck trailer and for removal of it from same, and possibly additionally for dumping it. The equipment comprises an auxiliary frame (2) pivotably mounted onto the chassis beams (1) of the truck or trailer by means of a transverse horizontal shaft or articulated joints (3) fitted to the chassis beams at a distance forwards from the support rolls fitted at the rear ends of the chassis beams (1), to which said auxiliary frame (2) a loading frame (10, 10 min , 10 sec ) is attached by one end pivotably by means of a transverse horizontal shaft or articulated joints (14), the free end of the said loading frame being provided with a grasping means (15, 15 min , 15 sec ) for engaging the grasping member of the exchange platform or container. The cylinder-piston device (11) independently pivoting the loading frame (10, 10 min , 10 sec ) in relation to the auxiliary frame (2) is at one end fixed to the free end of the auxiliary frame (2) by means of an articulated joint (12) and, at the other end, by means of an articulated joint (13) to the loading frame (10, 10 min , 10 min ). Thereat the articulated joint (14) between the loading frame (10, 10 min , 10 sec ) and the auxiliary frame (2) is located between the articulated joint (13) between auxiliary frame (2) and chassis beams (1) and the articulated joint (12) between auxiliary frame (2) and cylinder-piston device (11), for example, substantially equally far from both of them. The main cylinder-piston device (4) or two parallel main cylinder-piston devices operating the loading equipment have been arranged to be fixed, at one end, by means of articulated joint(s) (5), to the chassis (1) of the truck or trailer and, at the other end, by means of articulated joint(s) (6), to the auxiliary frame (2).
Patent FI-850298-L (FI)
Inventor: DORN GORDON LEE
IPC: C12Q1/04
Filed: 1985-01-23
Abstract: Methods and compositions are disclosed for the rapid identification of fungal pathogens. In a preferred method, a sample of human body fluid is obtained and subjected to analysis comprising inoculating a nutritive medium, incubating said inoculum for such time and temperature as is necessary for visible fungal colony formation, thereafter plating a sample of said visible fungi on miniature culture plates for example having the dimensions of about 33 x 75 x 5 millimeters, said plates containing differential fungal media, and thereafter indentifying fungal pathogens in a manner consistent with said medium selected. 
<??>In a related method utilizing the differential carbohydrate assimilation properties of fungal pathogens, a sample of human body fluid is obtained and subjected to analysis comprising inoculating a nutritive media, incubating said inoculum for such time and temperature as is necessary for visible fungal colony formation, thereafter inoculating a carbohydrate depleted medium with a sample of said visible fungi, incubating said inoculum for a period of time, thereafter plating a sample of said inoculated carbohydrate depleted medium on miniature culture plates, said plates containing differential carbohydrate assimilation media, and thereafter identifying said fungal pathogens in a manner consistent with said medium selected. 
<??>Novel compositions useful in practicing the disclosed methods are provided. These include an improved fungal growth medium, the improvement comprising the novel addition of ammonium ions to a medium comprising purified saponin, oxgall, a substrate for phenol oxidase and a supporting agent.
Patent FI-851993-L (FI)
Inventor: LUBBS EUGENE K
IPC: A61F6/04
Filed: 1985-05-17
Abstract: The invention relates to a process for producing collagen gels which can be used for making thin collagen film products which possess excellent mechanical properties. The raw material used in the process is pure animal tendons at room temperature, whose collagen content is at least 30% and which are virtually free of ligament tissue. The tendons are ground in the presence of approximately 65% by weight of water such that a collagen suspension is obtained. Rhozyme- 41 is then added to the suspension in order to break down the elastin and non-collagen material while the collagen structure remains virtually intact and is subsequently swollen with an acid, which can be selected from lactic acid, maleic acid, succinic acid, hydroxysuccinic acid, oxalic acid and tartaric acid, such that a swollen collagen suspension is obtained. The suspension is homogenized and deaerated so as to obtain a collagen gel. <IMAGE>
Patent IE-901046-L (IE)
Title: Gripping device and holder for handling a tubular fuse
IPC: H01H9/10
Filed: 1990-03-21
Abstract: Gripping device (1) for longitudinally fitting and removing a tubular fuse (32) for electrical medium- and high-voltage installations. The gripping device (1) having a sleeve-type cavity (4) for receiving a terminal electrode (25) of the tubular fuse (32). An annular element (26) having an ellipsoidal projection and bent into a V-shape around its short axis being fitted in the cavity (4) for providing a friction coupling to the terminal electrode (25). For displacing the annular element (26) in axial direction of the cavity (4) by hand, a sleeve (29) is slideably latched over the cavity (4) and provided with an edge (30) abutting the annular element (26). For making electrical contact to the terminal electrode (25) of the tubular fuse (32) contact elements (20) are arranged in the cavity (4). A conductor (6) extends from the cavity (4) for detachably connecting the terminal electrode (25) to a contact (39) of a holder (34) for receiving the tubular fuse (32).
Patent IE-42604-L (IE)
Title: Pharmaceutical preparation in the form of a foil
IPC: A61K9/70
Filed: 1975-07-03
Abstract: The pharmaceutical composition contains one or more pharmaceutical agents dissolved or uniformly suspended in a sheet whose material is soluble in water or organic solvents, preferably in both. It can be produced by dissolving or suspending the agent, introducing a sheet former which is soluble in water and/or soluble in organic solvents, drawing the resulting solution or suspension out to a film and drying the latter. The pharmaceutical sheet obtained in this way is divided into sections, e.g. dosage units. It is also possible to use release agents and fillers as well as the conventional flavourings, colorants etc. in the process.
[GB1510999A]
Patent IE-821543-L (IE)
Title: Expansible dowel
IPC: F16B13/08
Filed: 1982-06-28
Abstract: An expansion dowel assembly is formed of an axially extending dowel body and an expansion member. The dowel body has a support surface inclined relative to the axis of the dowel body along which the expansion member can be displaced for anchoring the dowel assembly in an opening such as a borehole. At least a portion of the support surface is in the form of a groove extending in the axial direction of the dowel body and the bottom of the groove is inclined so that the expansion member is forced radially outwardly away from the axis of the dowel body as it is displaced through the groove.
[US4464076A]
Patent IE-36837-L (IE)
Title: Beverage carbonation
IPC: C01B32/50
Filed: 1972-11-15
Abstract: 1382896 Cups PROCTER & GAMBLE CO 22 Nov 1972 [22 Nov 1971] 53888/72 Heading A4A [Also in Divisions B1 and B8] A drinking vessel 22 or 31 for preparing a carbonated drink has molecular sieve material with adsorbed carbon dioxide (see Division B 1) provided as an adherent layer on the inner surfaces of the vessel 22 or as an adherent moulded tablet 30 on the base of the vessel 31. The molecular sieve material (possibly with suitable additives for preparing the drink) may be held on the vessel by any inert insoluble adhesive, or if the vessel is of plastics by heat softening the material of the vessel to act as the adhesive.
[GB1382896A]
Patent IE-38218-L (IE)
Title: Substituted formylazapentadienenitriles
IPC: C07D241/00
Filed: 1973-09-06
Abstract: 1416598 Substituted formylazapentadienenitriles BYK GULDEN LOMBERG CHEMISCHE FABRIK GmbH 5 Sept 1973 [8 Sept 1972 (2)] 41665/73 Heading C2C Substituted formylazapentadienenitriles of the general formula and their salts with organic or inorganic acids, wherein R<SP>1</SP> and R<SP>2</SP>, same or different, are C 1-7 straight or branched alkyl radicals or C 3-6 cycloalkyl radicals or R<SP>1</SP> and R<SP>2</SP> together are a C 2-5 alkylene group in which optionally one or more methylene groups is replaced by -O-, -S- or -NR<SP>7</SP>- in which R<SP>7</SP> is H or C 1-7 alkyl, are prepared by hydrolysis of a compound of general formula wherein R<SP>8</SP> and R<SP>9</SP> are defined as R<SP>1</SP> and R<SP>2</SP> above, and, if desired, a free compound is converted into a salt or a salt is converted into a free compound or another salt. In the examples 3 - chloro - 5 - dimethylamino - 2 - formyl - 4- aza-2,4-pentadienenitrile is prepared. Bactericidal, fungicidal and insecticidal compositions comprise the above compounds as active agents together with a carrier.
[GB1416598A]
Patent IE-901654-L (IE)
Title: Vitamin and mineral supplements
IPC: A23L33/15
Filed: 1990-05-07
Abstract: Vitamin and mineral-fortified beverages, especially carbonated beverages are disclosed. These beverages are stable and contain vitamin A in the form of encapsulated beta -carotene, vitamin C and riboflavin. The beverages show enhanced calcium and iron absorption.
[EP0397232A1]
Patent IE-802237-L (IE)
Title: DIBENZ £b,f| AZEPINES.
IPC: C07D223/22
Filed: 1980-10-29
Abstract: The invention relates to a process for the manufacture of the known 5-carbamoyl-10-oxo-10,11-dihydro-5H-dibenz[b,f]azepine of the formula III which is characterized in that, for example, 5-cyano-5H-dibenz[b,f]azepine of the formula I is nitrated to form 5-cyano-10-nitro-5H-dibenz[b,f]azepine of the formula II, this is subjected to hydrolysis, then reduction, then the reduction product contained in the reaction mixture is subjected to hydrolysis and the end product of the formula III is isolated in pure form. The process is illustrated by the following reaction scheme:   <IMAGE>    <IMAGE> +TR  <IMAGE>  The invention relates also to new intermediates produced in these reactions.
Patent IE-45949-L (IE)
Title: Microwave filter
IPC: H01P1/208
Filed: 1977-12-19
Abstract: A filter for very short electromagnetic waves having a plurality of resonators which are coupled to one another and which are operated in the dualmode. The first and last resonators, as viewed in the direction of energy transmission, are provided with connection lines for the supply and discharge of electromagnetic energy. An additional coupling is provided between at least two filter circuits which are not directly consecutive in the electrical mode of operation and the individual resonators are arranged in juxtaposed rows. The resonators are arranged to be mechanically symmetrical relative to the center of the circuit, and the equivalent circuit diagram on which the construction is based is selected to be asymmetrical in respect of the element values, in such a manner that the number of additional couplings agrees with the theoretically determined, minimum number of additional couplings. The filter may be designed as a transit-time leveled band pass filter having two attenuation poles at finite frequencies in each case above and below the pass band and in which the resonators are arranged in two juxtaposed rows each of which contains three resonators and wherein either four or five additional couplings are provided.
[US4167713A]
Patent IE-832614-L (IE)
Title: Therapeutic compounds of platinum and palladium.
IPC: C07F15/00
Filed: 1983-11-09
Abstract: Compositions of matter are provided wherein cis-platinum (II) and cis-palladium (II) moieties having amine substituents are bonded to anionic macromolecular entities. These compositions of matter may have improved solubility in the plasma and are effective antitrypanosomal and antitumor agents in mammals. Alternatively, the compositions of matter may be insoluble in water and particularly adapted for in situ implantation into tumerous masses.
[US4584392A]
Patent IE-872621-L (IE)
Title: Portable data scanner apparatus
IPC: G06K7/10
Filed: 1987-09-29
Abstract: The present invention provides an integrated self-contained portable data scanner apparatus (1) which is suitable for long periods of uninterrupted handheld use for purpose such as the bar code scanning of inventory. The apparatus (1) includes a number of modules interconnected into a self-contained unit with no external cabling necessary. The basic modules are a scanner module (10), a data module (30) including one or more data processing components such as a keyboard (33), a display (35) or a microprocessor (37), and a removable rechargeable power module (40).
[EP0262943A2]
Patent IE-832959-L (IE)
Title: Electrical switch and actuating mechanism therefor
IPC: H01H15/02
Filed: 1983-12-15
Abstract: A switch has a dielectric frame (14) carrying a series of contact members (16, 18), with aligned pair of contacts (16A, 18A) disposed at an upper surface and terminal sections (22) projecting from the frame, a movable contact member (34) pivotally mounted on one of the contacts of each pair, a housing (48) mounted on the frame and a movable actuating member (50, 52) associated with respective contact members (34) to move them to connect and disconnect contacts (16A, 18A). The actuating members (50, 52) are slidable and carry spring members slidably engaging the housing (48) and respective members (34). A membrane (42) is sealingly secured to the frame to cover the contacts (16A, 18A) and member (34).
Patent NO-831428-L (NO)
Inventor: ZIEGENHORN JOACHIM
IPC: G01N33/92
Filed: 1983-04-22
Abstract: 1. Process for the determination of low density lipoproteine (LDL) in body fluids, characterised in that one adds to the high density lipoproteins (HDL) antibodies, which have been obtained with purified complete (HDL) fraction as immunogen, separates off insolubles formed and determines the (LDL) or one of its components in the supernatant.